Lawrence John H III 4
4 · PORTOLA PHARMACEUTICALS INC · Filed Feb 2, 2018
Insider Transaction Report
Form 4
Lawrence John H III
SVP, Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2018-01-31+27,500→ 27,500 totalExercise: $51.31Exp: 2028-01-30→ Common Stock (27,500 underlying) - Award
Common Stock
2018-01-31+6,875→ 6,875 total
Footnotes (2)
- [F1]Grant of Restricted Stock Units ("RSU") in consideration of services rendered. The RSU vests annually over three years commencing on March 1, 2018, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2013 Equity Incentive Plan) as of each such date.
- [F2]The option shall vest as follows: 1/48th of the shares subject to the option shall vest each month after January 1, 2018, subject to the Reporting Person's Continuous Service as of each such date.